Lisa R. Gerak

Affiliations: 
Pharmacology University of Tennessee Health Science Center, Memphis, TN, United States 
Area:
Behavioral pharmacology
Google:
"Lisa Gerak"
Mean distance: 17.14 (cluster 19)
 
SNBCP
Cross-listing: Chemistry Tree

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Gray RA, Heal DJ, Maguire DR, et al. (2022) Preclinical assessment of the abuse potential of purified botanical cannabidiol: self-administration, drug discrimination, and physical dependence. The Journal of Pharmacology and Experimental Therapeutics
Gerak LR, France CP. (2021) Effects of buprenorphine/lorcaserin mixtures on preference for heroin, cocaine, or saline over food using a concurrent choice procedure in rhesus monkeys. Drug and Alcohol Dependence. 227: 108991
France CP, Ahern G, Averick S, et al. (2020) Countermeasures for preventing and treating opioid overdose. Clinical Pharmacology and Therapeutics
Mada S, Gerak LR, Soyer A, et al. (2020) Behavioral effects of benzylideneoxymorphone (BOM), a low efficacy µ opioid receptor agonist and a δ opioid receptor antagonist. Psychopharmacology
Maguire DR, Gerak LR, Sanchez JJ, et al. (2020) Effects of acute and repeated treatment with methocinnamox, a mu opioid receptor antagonist, on fentanyl self-administration in rhesus monkeys. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
Gerak LR, Gould GG, Daws LC, et al. (2020) Methocinnamox Produces Sustained Antagonism of the Antinociceptive Effects of Morphine and Persistent Decreases in [ 3 H]DAMGO Binding to μ Opioid Receptors in Rat Cortex The Faseb Journal. 34: 1-1
Maguire DR, Gerak LR, Disney A, et al. (2020) Effects of Acute and Repeated Methocinnamox Treatment on Fentanyl Self‐administration in Rhesus Monkeys The Faseb Journal. 34: 1-1
Maguire DR, Gerak LR, Cami-Kobeci G, et al. (2019) OREX-1019: a novel treatment for opioid use disorder and relapse prevention. The Journal of Pharmacology and Experimental Therapeutics
Gerak LR, Maguire DR, France CP. (2019) Behavioral Pharmacology of Drugs Acting at Mu Opioid Receptors. Handbook of Experimental Pharmacology
Gerak LR, Minervini V, Latham E, et al. (2019) Methocinnamox (MCAM) produces long-lasting antagonism of the behavioral effects of µ opioid receptor agonists but not prolonged precipitated withdrawal in rats. The Journal of Pharmacology and Experimental Therapeutics
See more...